Risk factors for esophageal cancer development.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Surgical Oncology Clinics of North America

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.soc.2009.03.005PMID 19500737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Food group intake and risk of subtypes of esophageal and gastric cancer

  2008cited by this paper
• Barrett's Esophagus and Obesity: The Missing Part of the Puzzle

  2008cited by this paper
• Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis.

  2008cited by this paper
• Carbohydrate Consumption and Esophageal Cancer:An Ecological Assessment

  2008cited by this paper
• A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma.

  2008cited by this paper
• Three-Tiered Risk Stratification Model to Predict Progression in Barrett's Esophagus Using Epigenetic and Clinical Features

  2008cited by this paper
• Role of gastric atrophy in mediating negative association between Helicobacter pylori infection and reflux oesophagitis, Barrett’s oesophagus and oesophageal adenocarcinoma

  2008influential reference
• Extent of Low-Grade Dysplasia Is a Risk Factor for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus

  2008cited by this paper
• Abdominal Obesity and the Risk of Esophageal and Gastric Cardia Carcinomas

  2008cited by this paper
• Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis.

  2007cited by this paper
• Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study

  2007cited by this paper
• Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case–control study

  2007cited by this paper
• The Effect of Antireflux Surgery on Esophageal Carcinogenesis in Patients With Barrett Esophagus: A Systematic Review

  2007cited by this paper
• Mortality rates in patients with Barrett’s oesophagus

  2007cited by this paper
• NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma

  2007cited by this paper
• Extent of Low-Grade Dysplasia Is a Risk Factor for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus

  2007cited by this paper
• Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus

  2007cited by this paper
• Dietary Supplement Use and Risk of Neoplastic Progression in Esophageal Adenocarcinoma: A Prospective Study

  2007cited by this paper
• Meta analysis: cancer risk in Barrett’s oesophagus

  2007cited by this paper
• Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial.

  2007cited by this paper
• Esophagitis: Incidence and Risk of Esophageal Adenocarcinoma—A Population-Based Cohort Study

  2006cited by this paper
• Carbonated soft drinks and risk of esophageal adenocarcinoma: a population-based case-control study.

  2006cited by this paper
• Obesity: a challenge to esophagogastric junction integrity.

  2006cited by this paper
• Carbonated soft drink consumption and risk of esophageal adenocarcinoma.

  2006cited by this paper
• Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.

  2006cited by this paper
• general population Increasing incidence of Barrett's oesophagus in the

  2006cited by this paper
• Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma.

  2006cited by this paper
• Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.

  2006cited by this paper
• The effects of esomeprazole combined with aspirin or rofecoxib on prostaglandin E2 production in patients with Barrett's oesophagus

  2006cited by this paper
• Body Mass Index and Adenocarcinomas of the Esophagus or Gastric Cardia: A Systematic Review and Meta-analysis

  2006cited by this paper
• Familial risk for esophageal cancer: an updated epidemiologic study from Sweden.

  2006cited by this paper
• Risk Factors for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus

  2006cited by this paper
• Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia

  2006cited by this paper
• Low-grade dysplasia in Barrett's esophagus.

  2006cited by this paper
• Regular aspirin use and esophageal cancer risk

  2006cited by this paper
• Predictive factors of coexisting cancer in Barrett’s high-grade dysplasia

  2006cited by this paper
• Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk

  2005cited by this paper
• Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma.

  2005cited by this paper
• Increasing incidence of Barrett’s oesophagus in the general population

  2005cited by this paper
• The Incidence of Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Barrett's Esophagus Makes a Difference

  2005cited by this paper
• Meta-Analysis: Obesity and the Risk for Gastroesophageal Reflux Disease and Its Complications

  2005cited by this paper
• Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study.

  2005cited by this paper
• Fundoplication and the Risk of Esophageal Cancer in Gastroesophageal Reflux Disease: A Veterans Affairs Cohort Study

  2005cited by this paper
• Dysplasia and Risk of Further Neoplastic Progression in a Regional Veterans Administration Barrett's Cohort

  2005cited by this paper
• The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

  2005cited by this paper
• Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?

  2005cited by this paper
• Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study

  2005cited by this paper
• Nonsteroidal Anti-inflammatory Drugs and Risk of Esophageal and Gastric Cancer

  2005cited by this paper
• Marked Multi-Ethnic Variation of Esophageal and Gastric Cardia Carcinomas within the United States

  2004cited by this paper
• Low-grade dysplasia in Barrett's esophagus.

  2004cited by this paper
• Proton‐pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus

  2004cited by this paper
• Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.

  2004cited by this paper
• Height and Body Mass Index in Relation to Esophageal Cancer; 23-year Follow-up of Two Million Norwegian Men and Women

  2004cited by this paper
• Risk of oesophageal cancer in Barrett’s oesophagus and gastro-oesophageal reflux

  2004cited by this paper
• Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus

  2004cited by this paper
• Oesophageal cancer incidence and mortality in patients with long-segment Barrett's Oesophagus after a mean follow-up of 12.7 years

  2004cited by this paper
• Population attributable risks of esophageal and gastric cancers.

  2003cited by this paper
• Risk Factors for Dysplasia in Patients with Barrett's Esophagus (BE): Results from a Multicenter Consortium

  2003cited by this paper
• Long-term endoscopic surveillance of patients with Barrett's esophagus. incidence of dysplasia and adenocarcinoma: a prospective study

  2003cited by this paper
• Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.

  2003cited by this paper
• Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis

  2003cited by this paper
• Familial aggregation of Barrett’s oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults

  2002cited by this paper
• Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma

  2002cited by this paper
• Nutrient Intakes and Adenocarcinoma of the Esophagus and Distal Stomach

  2002cited by this paper
• p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.

  2002cited by this paper
• Observer variation in the diagnosis of superficial oesophageal adenocarcinoma

  2002cited by this paper
• Incidence and Survival Trends of Esophageal Carcinoma in the United States: Racial and Gender Differences by Histological Type

  2002cited by this paper
• Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA

  2002cited by this paper
• Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia.

  2001cited by this paper
• Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery.

  2001cited by this paper
• Family history of cancer and risk of esophageal and gastric cancers in the United States

  2001cited by this paper
• Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota

  2001cited by this paper
• Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression

  2001cited by this paper
• Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma.

  2001cited by this paper
• p53 protein overexpression in low grade dysplasia (LGD) in barrett's esophagus: Immunohistochemical marker predictive of progression

  2001cited by this paper
• p53 and neoplastic progression in barrett's esophagus

  2001cited by this paper
• Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.

  2001cited by this paper
• A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States)

  2001cited by this paper
• p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium.

  2001cited by this paper
• Risk Stratification of Barrett's Esophagus: Updated Prospective Multivariate Analysis

  2001cited by this paper
• Antioxidants and cancers of the esophagus and gastric cardia

  2000cited by this paper
• Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets

  2000cited by this paper
• Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

  2000cited by this paper
• Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.

  2000cited by this paper
• High-Grade dysplasia in Barrett’s esophagus: Surveillance or operation?

  2000cited by this paper
• Heredity and risk of cancer of the esophagus and gastric cardia.

  2000cited by this paper
• The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression

  2000cited by this paper
• The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia

  2000cited by this paper
• Long-term follow-up of Barrett's high-grade dysplasia

  2000cited by this paper
• Prospective evaluation of the prevalence of gastric helicobacter pylori infection in patients with GERD, barrett's esophagus, barrett's dysplasia, and barrett's adenocarcinoma

  2000cited by this paper
• Effect of Segment Length on Risk for Neoplastic Progression in Patients with Barrett Esophagus

  2000cited by this paper
• Association between Medications That Relax the Lower Esophageal Sphincter and Risk for Esophageal Adenocarcinoma

  2000cited by this paper
• Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy.

  2000cited by this paper
• p53-mutant clones and field effects in Barrett's esophagus.

  1999cited by this paper
• Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

  1999cited by this paper
• Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia

  1999cited by this paper
• Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.

  1999cited by this paper
• Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice.

  1999cited by this paper
• The economic impact of the diagnosis of dysplasia in Barrett's esophagus

  1998cited by this paper
• Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.

  1998cited by this paper

• Precision Medicine in Thoracic Surgery: Esophageal Cancer.

  2025cites this paper
• Machine learning-enabled prediction of bone metastasis in esophageal cancer

  2025cites this paper
• Surgical Timing and Outcomes in Esophageal Cancer: Insights from One- and Two-Stage Esophagectomies in a Polish Cohort

  2025cites this paper
• The Swedish Standardized Course of Care—Diagnostic Efficacy in Esophageal and Gastric Cancer

  2023cites this paper
• The Emerging Role of Long Non-Coding RNAs in Esophageal Cancer: Functions in Tumorigenesis and Clinical Implications

  2022cites this paper
• CPEB3 overexpression caused by miR-106b-5p inhibition inhibits esophageal carcinoma in-vitro progression and metastasis

  2022cites this paper
• TET3 governs malignant behaviors and unfavorable prognosis of esophageal squamous cell carcinoma by activating the PI3K/AKT/GSK3β/β-catenin pathway

  2022cites this paper
• Associations between Lifestyle Habits, Perceived Symptoms and Gastroesophageal Reflux Disease in Patients Seeking Health Check-Ups

  2021cites this paper
• Helicobacter pylori and GERD

  2021cites this paper
• Immuno-Oncology of Oesophageal Cancer

  2020cites this paper
• Prone approach for minimally invasive esophagectomy: history and surgical approach

  2020cites this paper
• The Understanding of Dignity Among In-Hospital Patients Living With Incurable Esophageal Cancer

  2020cites this paper
• Epidemiological pattern of malignant neoplasia of the esophagus in the region of ABC- So Paulo, Brazil between the years of 2008 and 2017

  2020cites this paper
• SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.

  2020cites this paper
• Overweight Patterns Between Childhood and Early Adulthood and Esophageal and Gastric Cardia Adenocarcinoma Risk

  2019cites this paper
• Nutritional and Epigenetics Implications in Esophageal Cancer

  2019cites this paper
• Squamous Cell Carcinoma: Esophagus

  2019cites this paper
• Diabetes in relation to Barrett’s esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett’s and Esophageal Adenocarcinoma Consortium

  2019cites this paper
• Prognostic Value of Texture Analysis Based on Pretreatment DWI-Weighted MRI for Esophageal Squamous Cell Carcinoma Patients Treated With Concurrent Chemo-Radiotherapy

  2019influential citation
• Esophageal Cancer

  2019cites this paper
• Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma

  2018cites this paper
• Dietary vitamin B intake and the risk of esophageal cancer: a meta-analysis

  2018cites this paper
• Relationship between the Methylation of Folic Acid Metabolism-Related Genes and the Incidence and Prognosis of Esophageal Cancer among Ethnic Kazakhs

  2018cites this paper
• Comparison of outcomes between minimally invasive oesophagectomy and open oesophagectomy for oesophageal cancer

  2017cites this paper
• Effects of javanica oil emulsion injection combined with radiotherapy versus radiotherapy alone on the efficacy and safety in patients with esophageal cancer: a pooled analysis of 1269 cases.

  2017cites this paper
• Factors associated with the high prevalence of oesophageal cancer in Western Kenya: a review

  2017cites this paper
• Impact of enhanced recovery program on patients with esophageal cancer in comparison with traditional care

  2017cites this paper
• Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies

  2017cites this paper
• Genomic regions associated with susceptibility to Barrett’s esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study

  2017cites this paper
• Design and Development of Compact Multiphoton Microscopes

  2016cites this paper
• Expression and role of HSP 90 α in esophageal squamous cell carcinoma

  2016cites this paper
• Label-free multi-photon imaging of dysplasia in Barrett's esophagus.

  2016cites this paper
• Investigating the natural history of Barrett’s oesophagus and its progression to oesophageal adenocarcinoma in the setting of improved assessment techniques and endoscopic therapy

  2016cites this paper
• Esophageal Adenocarcinoma, More Than One Entity? : A clinical and molecular analysis.

  2016cites this paper
• Association between selenium levels and oesophageal adenocarcinoma risk: evidence from a meta-analysis

  2016cites this paper
• Functional polymorphisms in the IL-10 gene with susceptibility to esophageal, nasopharyngeal, and oral cancers

  2016cites this paper
• Cross-Disease Analysis Reveals Novel Risk Genes for Esophageal Adenocarcinoma

  2016cites this paper
• An Unusual Presentation of Esophageal Cancer: A Case Report and Review of Literature

  2016cites this paper
• Esophageal Cancer in Brunei Darussalam over a three Decade Period: an Epidemiologic Study of Trends and Differences between Genders and Racial Groups.

  2015influential citation
• Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA)

  2015cites this paper
• Understanding Complete Pathologic Response in Oesophageal Cancer: Implications for Management and Survival

  2015cites this paper
• Regional variation in incidence for smoking and alcohol related cancers in Belgium.

  2015cites this paper
• FOXQ1 promotes esophageal cancer proliferation and metastasis by negatively modulating CDH1.

  2015cites this paper
• Confocal foveated endomicroscope for the detection of esophageal carcinoma.

  2015cites this paper
• Dietary Risk Reduction Factors for the Barrett’s Esophagus-Esophageal Adenocarcinoma Continuum: A Review of the Recent Literature

  2015cites this paper
• Management and outcomes of localized esophageal and gastroesophageal junction cancer in older patients.

  2015cites this paper
• Epithelial-to-mesenchymal transition in human esophageal cancer associates with tumor progression and patient's survival.

  2014cites this paper
• Amiloride and guggulsterone suppression of esophageal cancer cell growth in vitro and in nude mouse xenografts

  2014cites this paper
• Epidemiological characteristics and prediction of esophageal cancer mortality in China from 1991 to 2012.

  2014cites this paper
• Current management of esophageal cancer.

  2014cites this paper
• Dietary Intake of Flavonoids, Barrett's Esophagus Development, and Esophageal and Gastric Cancer Incidence and Survival

  2014cites this paper
• Multimodal Foveated Endomicroscope for the Detection of Esophageal Adenocarcinoma in Barrett’s Esophagus

  2014cites this paper
• Esophageal Carcinogenesis

  2014cites this paper
• Area-Level Attributes and Esophageal Adenocarcinoma in Surveillance, Epidemiology and End Results Registries

  2013cites this paper
• Radiofrequency ablation for Barrett's esophagus, for whom and by whom?

  2013cites this paper
• Expanding the Lauren classification: a new gastric cancer subtype?

  2013cites this paper
• Upper Gastrointestinal Cancer and Reflux Disease

  2013cites this paper
• Cancer: Epidemiology of Gastrointestinal Cancers Other than Colorectal Cancers

  2013cites this paper
• Barrett's Esophagus: Diagnosis and Surveillance

  2013cites this paper
• Risk Factors for Rising Incidence of Esophageal and Gastric Cardia Adenocarcinoma

  2013cites this paper
• Methylenetetrahydrofolate reductase genetic polymorphisms and esophageal squamous cell carcinoma susceptibility: A meta-analysis of case-control studies

  2013cites this paper
• Barrett's esophagus surveillance: time to rethink if one size fits all?

  2013cites this paper
• Methylenetetrahydrofolate reductase genetic polymorphisms and esophageal squamous cell carcinoma susceptibility: a meta-analysis of case-control studies.

  2013cites this paper
• Atorvastatin correlates with decreased risk of esophageal cancer: a population-based case–control study from Taiwan

  2012cites this paper
• Establishment of rules for interpreting ultraviolet autofluorescence microscopy images for noninvasive detection of Barrett's esophagus and dysplasia.

  2012cites this paper
• Folate intake, methylenetetrahydrofolate reductase polymorphisms in association with the prognosis of esophageal squamous cell carcinoma.

  2012cites this paper
• Urinary metabolomic signature of esophageal cancer and Barrett’s esophagus

  2012cites this paper
• Esophageal cancer in Canada: trends according to morphology and anatomical location.

  2012cites this paper
• The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid.

  2012cites this paper
• Helicobacter pylori may cause otitis media with effusion: a pilot study.

  2012cites this paper
• Effects of Cigarette Smoke and Ethanol Intake on Mouse Oesophageal Mucosa Changes Induced by Dietary Zinc Deficiency and Deoxycholic Acid Supplementation

  2012cites this paper
• Esophageal Disease in Older Patients

  2012cites this paper
• Preoperative Work-up: PET and PET-CT

  2012cites this paper
• Epidemiology of Esophageal and Hypopharyngeal Squamous Cell Carcinoma

  2012influential citation
• Biomarkers in esophageal cancer

  2012cites this paper
• Diagnosis and Surveillance of Barrett's Esophagus

  2012cites this paper
• 27. Barrett's Esophagus

  2012cites this paper
• Barrett ’ s esophagus , esophageal and esophagogastric junction adenocarcinomas : The role of diet Endobrachyœsophage , adénocarcinome de l ’ œsophage et de la jonction œsogastrique : le rôle de la nutrition

  2011cites this paper
• Reply to Letter to the Editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett’s esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First)

  2011cites this paper
• Tobacco Smoking and Esophageal and Gastric Cardia Adenocarcinoma: A Meta-analysis

  2011cites this paper
• Barrett's esophagus surveillance: When, how often, does it work?

  2011cites this paper
• Road map to esophagectomy for nurses.

  2011influential citation
• Does immigration play a role in the risk of gastric cancer by site and by histological type? A study of first-generation immigrants in Sweden

  2011cites this paper
• COUNTY AND CENSUS TRACT SOCIOECONOMIC ATTRIBUTES OF ESOPHAGEAL ADENOCARCINOMA CASES SEER 15 (2000-2007)

  2011cites this paper
• Barrett's esophagus, esophageal and esophagogastric junction adenocarcinomas: the role of diet.

  2011cites this paper
• Traitement des adénocarcinomes de l’œsophage☆

  2011cites this paper
• Management of esophageal adenocarcinoma.

  2011cites this paper
• NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer.

  2011cites this paper
• Esophageal cancer risk among immigrants in Sweden

  2011cites this paper
• Risk factors for neoplastic progression in Barrett's esophagus.

  2011cites this paper
• Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma

  2011cites this paper
• An expert opinion on esophageal cancer therapy

  2011cites this paper
• Toll-Like Receptor 9 Is a Novel Biomarker for Esophageal Squamous Cell Dysplasia and Squamous Cell Carcinoma Progression

  2011cites this paper
• Bile Acids and their Role in Autophagy Resistance: The Link Between Gastro-Esophageal Reflux Disease (GERD) and Development of Barrett's Esophagus

  2011cites this paper
• Variation in Age at Cancer Diagnosis in Familial versus Nonfamilial Barrett's Esophagus

  2011cites this paper
• Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology

  2011cites this paper
• Aberrant DNA methylation in oesophageal cancer and Barrett’s oesophagus.

  2010cites this paper
• Comparison of lifestyle and living environment among high risk immigrant and low risk host residents: implications for esophageal cancer etiology.

  2010cites this paper
• Polyphenols and aging.

  2010cites this paper
• MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma

  2010cites this paper